Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations

Abstract Alzheimer's disease (AD) staging criteria lack standardized, empirical description. Well‐defined AD staging criteria are an important consideration in protocol design, influencing a more standardized inclusion/exclusion criteria and defining what constitutes meaningful differentiation among...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ronald C. Petersen, Ana Graf, Chris Brady, Susan De Santi, Hana Florian, Jaren Landen, Mike Pontecorvo, Christopher Randolph, Kaycee M. Sink, Maria C. Carrillo, Christopher J. Weber
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-10-01
coleção:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Assuntos:	Alzheimer's disease amyloid biomarkers clinical trials cognition cognitive impairment
Acesso em linha:	https://doi.org/10.1002/trc2.12434
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!